Concussions have become a critical public health issue, resulting in a substantial increase in research. For a clinician searching for the most up-to-date information, Concussion can serve as the go-to journal.
(PRWEB UK) 24 February 2015
Future Science Group (FSG) has launched Concussion, a new open access journal that publishes original research, reviews and commentaries addressing the assessment, management and short and long term implications of this subset of traumatic brain injury, which is gaining increasing attention.
“As professional sports leagues and parents of young athletes alike are placing more emphasis on concussion prevention and protocol, exciting developments in biomarker research are shedding new light on how to gauge the severity of concussions immediately after injury, as well as indicating future prognosis,” said Commissioning Editor Hannah Wilson. “Using the open access model, we hope to make the latest advances in basic, translational and clinical research in the field available to the broadest possible audience of readers.”
Topics covered by Concussion include:
- Studies and trials in concussion
- Biomarkers for assessment and predicting adverse effects
- Optimum biomarker selection, validation and application
- Management, including return-to-play decisions in sports
Concussion will be supported by an international editorial board consisting of leading experts in the field. Board member Steven P. Broglio, University of Michigan, MI, USA explained: “Concussions have become a critical public health issue, resulting in a substantial increase in research. For a clinician searching for the most up-to-date information, Concussion can serve as the go-to journal.”
The journal will consider publication of original research, review and opinion articles. All articles submitted to Concussion are subject to peer review by a minimum of three independent experts. Unsolicited article proposals are welcomed and authors are required to comply fully with the journal's Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP2.The journal follows a gold open access model, publishing all articles under the Creative Commons CC-BY license to allow maximum dissemination.
To submit an article, or for further information, contact the Commissioning Editor Hannah Wilson: hannah.wilson(AT)futuremedicine.com.
About Future Science Group
Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological and scientific research. FSG’s portfolio includes two imprints, Future Science and Future Medicine. Both publish eBooks and journals. In addition to this core publishing portfolios, FSG develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, Epigenomics, Nanomedicine and the award-winning Regenerative Medicine.
The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards. http://www.futuresciencegroup.com